Commentary: Improved patient outcomes remain elusive after intensive imaging surveillance for high-risk melanoma.
Dermatology Service, Department of Veterans Affairs Palo Alto Health Care System, Palo Alto, California; Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, California. Electronic address: sswetter@stanford.edu.
Susan M
SM
Swetter
D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D008991:Monitoring, Physiologic / Q000379:methods; D064847:Multimodal Imaging / Q000379:methods*; D009361:Neoplasm Invasiveness / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D009367:Neoplasm Staging; D011379:Prognosis; D012680:Sensitivity and Specificity; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D016019:Survival Analysis; D000096142:Cutaneous Malignant Melanoma
computed tomography; follow-up studies; melanoma; metastasis; recurrence; ultrasonography